Addressing Opioid Exposure in Pregnancy — Best Practices for Women and Newborns
About This Event
As opioid abuse has soared, more pregnant woman are also using opioids, and more infants are diagnosed with neonatal abstinence syndrome (NAS). Pregnant women often do not receive optimal diagnosis and treatment for their opioid use. The care of newborns with NAS often involves long hospital stays and separation from their mothers.
This one-day conference highlighted a new approach, one that improves care for mother and newborns, and reduces a newborn’s hospital stay from an average of 30 days to just five.
We invite you to watch videos from three of the speakers:
- Matthew Grossman, MD, assistant professor of pediatrics, Yale School of Medicine
- Corey Waller, MD, principal with Health Management Associates and an addiction medicine specialist
- Elliott Main, MD, medical director, California Maternal Quality Care Collaborative
In addition to the presentations above, watch Dr. Corey Waller’s highly engaging video Addiction Neuroscience 101 on YouTube (23 minutes).
California’s MAT Expansion Program is supporting a statewide effort to improve care of perinatal women with opioid use disorder and their newborns focused on evidence-based, family-centered treatment. The program is led by Health Management Associates, the California Maternity Quality Care Collaborative, and the California Perinatal Quality Care Collaborative. In preparation for this work, the California Health Care Foundation commissioned a report from the Urban Institute to study the landscape of perinatal opioid use disorder, neonatal abstinence syndrome, and analyze geographic barriers to treatment.